More importantly, the METTL14/ZFP14 axis was shown to suppress several malignant features of ccRCC cells, including proliferation, migratory ability, invasiveness and metastasis, offering new potential therapeutic strategies for this life‐threatening malignancy. The gene discussed is METTL14; the disease is nonpapillary renal cell carcinoma.